Loading clinical trials...
Loading clinical trials...
Glioblastoma (GBM) is a highly malignant, incurable primary brain tumor. Due to the nature of this disease and the extent of the treatment (surgery followed by chemoradiation according to the Stupp tr...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Maastricht Radiation Oncology
Collaborators
NCT07100730 · Neoplastic Disease, Glioblastoma, and more
NCT07420543 · Brain Tumors and/or Solid Tumors Including, Glioblastoma, and more
NCT05911230 · Glioblastoma (GBM)
NCT07472387 · Glioblastoma (GBM)
NCT07409584 · Glioblastoma (GBM)
Maastricht Radiation Oncology (Maastro)
Maastricht, Limburg
Verbeeten Insitute Tilburg
Tilburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions